Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
02/2012
02/07/2012CA2250381C Type c lectins
02/02/2012WO2012016245A2 Fibronectin cradle molecules and libraries thereof
02/02/2012WO2012016227A2 Antibodies with modified isoelectric points
02/02/2012WO2012016107A1 Methods and kits for detection of salmonella enteritidis and related serovars
02/02/2012WO2012015674A1 THERAPEUTIC USES OF AN FGFR1c ANTIBODY
02/02/2012WO2012014997A1 Anti-fdp monoclonal antibody, fdp measurement reagent and reagent kit using same, and fdp measurement method
02/02/2012WO2012014996A1 Reagent and reagent kit for measurement of fdp, and measurement method
02/02/2012WO2012013980A1 Stabilized aqueous antibody compositions
02/02/2012WO2012013930A2 Process for purifying proteins
02/02/2012WO2012013813A1 Epitopes of the human pdgf receptor able to bind human auto-antibodies, antibodies and uses thereof
02/02/2012WO2012013609A1 Methods and compositions for liver cancer therapy
02/02/2012WO2011156252A3 Sulfation of wnt pathway proteins
02/02/2012WO2011151076A3 Monoclonal antibodies targeting amyloid beta oligomers
02/02/2012WO2011126577A3 Method for the generation of monoclonal antibodies derived from human b cells
02/02/2012WO2011113019A3 Ctla4 proteins and their uses
02/02/2012WO2011106401A3 Methods and compositions relating to multiciliate cell differentiation
02/02/2012US20120030839 Expression and High-Throughput Screening of Complex Expressed DNA Libraries in Filamentous Fungi
02/02/2012US20120030838 Novel fungal enzymes
02/02/2012US20120030780 Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (mds)
02/02/2012US20120029472 Tnfr25 agonists to enhance immune responses to vaccines
02/02/2012US20120029172 Humanized GM-CSF antibodies
02/02/2012US20120029171 Method of Producing a Plurality of Isolated Antibodies to a Plurality of Cognate Antigens
02/02/2012US20120028896 Use of fibroblast growth factor fragments
02/02/2012US20120028878 Membrane Evaporation for Generating Highly Concentrated Protein Therapeutics
02/02/2012US20120028841 Focused libraries of genetic packages
02/02/2012US20120028840 Focused libraries of genetic packages
02/02/2012US20120028836 Use of protein satb2 as a marker for colorectal cancer
02/02/2012US20120028359 Production process of gender-specific serum and biomarker using the serum
02/02/2012US20120028347 Agent for suppressing replication of hiv and use thereof
02/02/2012US20120028304 Antibodies with modified isoelectric points
02/02/2012US20120028300 Whitefly Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof
02/02/2012US20120028281 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
02/02/2012US20120028267 Method for increasing sensitivity using linker and spacer in carbon nanotube-based biosensor
02/02/2012US20120028266 Discovery of candidate biomarkers of in vivo apoptosis by global profiling of caspase cleavage sites
02/02/2012US20120028258 Receptor gene screening for detecting or diagnosing cancer
02/02/2012US20120028252 Human mena isoforms serve as markers of epithelial to mesenchymal transition and sensitivity to egfr inhibition in human cancer cells
02/02/2012US20120027843 Hb-egf bound protein complex
02/02/2012US20120027801 Polypeptides from neisseria meningitidis
02/02/2012US20120027799 Compositions and methods for treating or preventing inflammatory bowel disease and colon cancer
02/02/2012US20120027798 Antibody gene transfer and recombinant aav therefor
02/02/2012US20120027784 Monomethylvaline compounds capable of conjugation to ligands
02/02/2012US20120027783 Monomethylvaline compounds capable of conjugation to ligands
02/02/2012US20120027780 Anticoagulant antidotes
02/02/2012US20120027779 Induction of p53 expression by neutralization of neuropilin-2 for the treatment of cancers
02/02/2012US20120027778 Frizzled-Binding Agents and Uses Thereof
02/02/2012US20120027777 Ljungan virus with improved replication characteristics
02/02/2012US20120027776 Diabetic model
02/02/2012US20120027773 Anti-ron antibodies
02/02/2012US20120027772 Therapeutic protein formulations
02/02/2012US20120027771 Affinity purified human polyclonal antibodies against viral, bacterial and/or fungal infections and methods of making and using the same
02/02/2012US20120027769 Anti-rhd monoclonal antibodies
02/02/2012US20120027768 Monoclonal antibody production by ebv transformation of b cells
02/02/2012US20120027765 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
02/02/2012US20120027764 Novel polypeptide, cdna encoding the same, and use thereof
02/02/2012US20120027763 Antibody for Targeted induction of Apoptosis, CDC and ADCC mediated killing of Cancer cells, TBL-CLN1
02/02/2012US20120027762 Immunogenic compositions and diagnostic and therapeutic uses thereof
02/02/2012US20120027761 Treatment of Inflammatory Diseases by Inhibiting Cold-Inducible RNA-Binding Protein (CIRP)
02/02/2012US20120027760 Adiponectin receptor and gene encoding the same
02/02/2012US20120027759 Methods of enhancing t cell responsiveness
02/02/2012US20120027758 Use of anti-cd100 antibodies
02/02/2012US20120027755 Prevention and treatment of alzheimer's disease
02/02/2012US20120027753 MicroRNAs in Never-Smokers and Related Materials and Methods
02/02/2012US20120027751 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
02/02/2012CA2806909A1 Safe and functional humanized antibodies
02/02/2012CA2806252A1 Antibodies with modified isoelectric points
02/02/2012CA2806157A1 Methods and compositions for liver cancer therapy
02/02/2012CA2805862A1 Fibronectin cradle molecules and libraries thereof
02/02/2012CA2804512A1 Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin fc compositions
02/02/2012CA2804099A1 Process for purifying proteins
02/02/2012CA2729798A1 Novel anti-vegf biologics
02/01/2012EP2412817A1 Method for removing viruses in high-concentration monoclonal antibody solution
02/01/2012EP2412808A1 Lh-type bispecific antibody
02/01/2012EP2412805A1 Gene involved in immortalization of human cancer cell and use thereof
02/01/2012EP2412728A2 Therapeutic and diagnostic methods and compositions targeting 4IG-B7-H3 and its counterpart NK cell receptor
02/01/2012EP2412725A2 Antibodies against CD79b for the treatment of tumor of hematopoeitic origin
02/01/2012EP2412722A1 A method for identification, isolation and production of antigens to a specific pathogen
02/01/2012EP2412721A1 Koi herpes virus-specific antibody and antigen thereof
02/01/2012EP2412384A1 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
02/01/2012EP2411522A1 Aberrant mitochondrial dna, associated fusion transcripts and translation products and hybridization probes therefor
02/01/2012EP2411417A1 Sialylated antigen-specific antibodies for treatment or prophylaxis of unwanted inflammatory immune reactions and methods of producing them
02/01/2012EP2411416A1 Anti-mesothelin antibodies
02/01/2012EP2411415A1 Oncofetal antigen/immature laminin receptor antibodies for diagnostic and clinical applications
02/01/2012EP2411414A1 Anti-fgfr3 antibodies and methods using same
02/01/2012EP2411413A1 Compounds compositions and methods of treating cancer and fibrotic diseases
02/01/2012EP2411412A1 Humanized antibodies against light and uses thereof
02/01/2012EP2411411A1 Novel anti-alpha5beta1 antibodies and uses thereof
02/01/2012EP2411410A2 Compositions and methods for screening and using compounds antagonizing spore-surface interactions
02/01/2012EP2411409A2 Antibody composition with altered fab sialylation
02/01/2012EP2411408A2 Soluble "heavy-chain only" antibodies
02/01/2012EP2411407A1 Compositions and methods for using multispecific-binding proteins comprising an antibody-receptor combination
02/01/2012EP2411125A1 Membrane evaporation for generating highly concentrated protein therapeutics
02/01/2012EP2411054A2 Drug fusions and conjugates
02/01/2012EP2411051A1 Rapid antemortem detection of infectious agents
02/01/2012EP2411050A2 Antibody constant domain regions and uses thereof
02/01/2012EP2411047A1 Vaccine for protection against streptococcus suis bacteria of various serotypes
02/01/2012EP2411034A1 Promotion of neuronal integration in neural stem cell grafts
02/01/2012EP2176296B1 Anti-cd79b antibodies and immunoconjugates and methods of use
02/01/2012EP1699925B1 DCRS5 and p19 antagonists for therapy of asthma, allergy and COPD
02/01/2012EP1472353B1 Group b streptococcus antigen
02/01/2012EP0998486B2 Protein recovery by chromatography followed by filtration upon a charged layer
1 ... 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 ... 1494